Literature DB >> 16391200

Imaging thromboembolism with fibrin-avid 99mTc-peptide: evaluation in swine.

Mohan R Aruva1, Judy Daviau, Shubh S Sharma, Mathew L Thakur.   

Abstract

UNLABELLED: A pentapeptide, Gly-Pro-Arg-Pro-Pro, with high affinity for alpha-chain-fibrin was labeled with (99m)Tc ((99m)Tc-TP850) and evaluated in swine to image experimental venous thromboembolism (deep vein thrombosis [DVT]) and pulmonary embolism (PE).
METHODS: Scatchard analysis was performed to determine fibrin affinity for TP850 and the number of binding sites (receptors) per milligram of fibrin. DVT was induced in the left jugular vein and PE was induced by introducing a preformed autologous blood clot into the right atrium using a 7-French introducer sheath inserted into the right jugular vein. (99m)Tc-TP850 was injected at 4, 24, 48, 72, 96, or 120 h later. Animals were imaged for up to 4 h after injection, heparinized, and sacrificed. Lungs were extirpated, radiographed, and imaged, and the PE was removed. Other tissues, including blood and normal lungs, were harvested and, concomitantly, (99m)Tc was counted for determination of target-to-tissue ratios and the percentage injected dose per gram of tissue.
RESULTS: The affinity for human fibrin was 10(-9) mol/L and there were >10(15) receptors per milligram of fibrin. DVT and PE were visualized for up to 4 h after injection with high DVT/blood (7.9-22.6), DVT/muscle (31.1-89.4), PE/blood (1-155), and PE/lung (0.8-245) ratios. Thereafter, the PEs fragmented spontaneously below the spatial resolution of the gamma-camera and, despite the high associated radioactivity, could not be localized in vivo. The fragmented clots were detectable by scintigraphy on excised lungs and provided excellent concordance with radiograms.
CONCLUSION: (99m)Tc-TP850 with its modest affinity (10(-9) mol/L), rapid blood clearance, and high DVT and PE uptake is a promising agent for imaging vascular thrombosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16391200      PMCID: PMC1525044     

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  20 in total

1.  Imaging thromboembolism with Tc-99m-labeled thrombospondin receptor analogs TP-1201 and TP-1300.

Authors:  V R Pallela; M L Thakur; P M Consigny; P S Rao; D Vasileva-Belnikolavska; R Shi
Journal:  Thromb Res       Date:  1999-02-15       Impact factor: 3.944

2.  99mTc-labeled vasoactive intestinal peptide analog for rapid localization of tumors in humans.

Authors:  M L Thakur; C S Marcus; S Saeed; V Pallela; C Minami; L Diggles; H Le Pham; R Ahdoot; E A Kalinowski
Journal:  J Nucl Med       Date:  2000-01       Impact factor: 10.057

3.  Thrombosis and atherosclerosis: the organization of pulmonary thromboemboli in the pig. Individual phospholipids, fatty acid composition of lecithin, sphingomyelin, esterified cholesterol, and 3 H-cholesterol specific activity.

Authors:  I H Craig; F P Bell; C J Schwartz
Journal:  Exp Mol Pathol       Date:  1973-06       Impact factor: 3.362

4.  Amino acids and peptides. XVIII. Synthetic peptides related to N-terminal portion of fibrin alpha-chain and their inhibitory effect on fibrinogen/thrombin clotting.

Authors:  K Kawasaki; M Miyano; K Hirase; M Iwamoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1993-05       Impact factor: 1.645

5.  Some species differences in fibrinolysis and blood coagulation.

Authors:  R G Mason; M S Read
Journal:  J Biomed Mater Res       Date:  1971-01

6.  Thrombus imaging with technetium-99m synthetic peptides based upon the binding domain of a monoclonal antibody to activated platelets.

Authors:  L C Knight; R Radcliffe; A H Maurer; J D Rodwell; V L Alvarez
Journal:  J Nucl Med       Date:  1994-02       Impact factor: 10.057

7.  PET imaging of oncogene overexpression using 64Cu-vasoactive intestinal peptide (VIP) analog: comparison with 99mTc-VIP analog.

Authors:  Mathew L Thakur; Mohan R Aruva; Jean Gariepy; Paul Acton; Satish Rattan; Shyam Prasad; Eric Wickstrom; Abass Alavi
Journal:  J Nucl Med       Date:  2004-08       Impact factor: 10.057

8.  Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data.

Authors:  Kenneth T Horlander; David M Mannino; Kenneth V Leeper
Journal:  Arch Intern Med       Date:  2003-07-28

Review 9.  Diagnosis of pulmonary embolism with various imaging modalities.

Authors:  Sunita D Srivastava; Matthew J Eagleton; Lazar J Greenfield
Journal:  Semin Vasc Surg       Date:  2004-06       Impact factor: 1.000

10.  Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers.

Authors:  A P Laudano; R F Doolittle
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

View more
  13 in total

1.  Synthesis and Biological Evaluation of Cyclic [99mTc]-HYNIC-CGPRPPC as a Fibrin-Binding Peptide for Molecular Imaging of Thrombosis and Its Comparison with [99mTc]-HYNIC-GPRPP.

Authors:  Sedigheh Rezaeianpour; Atefeh Hajiagha Bozorgi; Abolghasem Moghimi; Ameneh Almasi; Saeed Balalaie; Sorour Ramezanpour; Sanaz Nasoohi; Seyed Mohammad Mazidi; Parham Geramifar; Ahmad Bitarafan-Rajabi; Soraya Shahhosseini
Journal:  Mol Imaging Biol       Date:  2017-04       Impact factor: 3.488

Review 2.  The role of molecular imaging in diagnosis of deep vein thrombosis.

Authors:  Sina Houshmand; Ali Salavati; Søren Hess; Mudalsha Ravina; Abass Alavi
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-08-15

3.  Structure - relaxivity relationships among targeted MR contrast agents.

Authors:  Peter Caravan; Zhaoda Zhang
Journal:  Eur J Inorg Chem       Date:  2012-04       Impact factor: 2.524

4.  Nanomedicine and Cardiovascular Disease.

Authors:  Jason R McCarthy
Journal:  Curr Cardiovasc Imaging Rep       Date:  2010-02

5.  The Protein Corona of Plant Virus Nanoparticles Influences their Dispersion Properties, Cellular Interactions, and In Vivo Fates.

Authors:  Andrzej S Pitek; Amy M Wen; Sourabh Shukla; Nicole F Steinmetz
Journal:  Small       Date:  2016-02-08       Impact factor: 13.281

6.  Evaluation of 99mTc-labeled cyclic RGD peptide with a PEG4 linker for thrombosis imaging: comparison with DMP444.

Authors:  Wei Fang; Jia He; Young-Seung Kim; Yang Zhou; Shuang Liu
Journal:  Bioconjug Chem       Date:  2011-08-02       Impact factor: 4.774

7.  Multimodal nanoagents for the detection of intravascular thrombi.

Authors:  Jason R McCarthy; Purvish Patel; Ion Botnaru; Pouneh Haghayeghi; Ralph Weissleder; Farouc A Jaffer
Journal:  Bioconjug Chem       Date:  2009-06       Impact factor: 4.774

8.  Optical imaging of fibrin deposition to elucidate participation of mast cells in foreign body responses.

Authors:  Yi-Ting Tsai; Jun Zhou; Hong Weng; Ewin N Tang; David W Baker; Liping Tang
Journal:  Biomaterials       Date:  2013-12-14       Impact factor: 12.479

9.  The evolution of fibrin-specific targeting strategies.

Authors:  Victoria L Stefanelli; Thomas H Barker
Journal:  J Mater Chem B       Date:  2015-01-13       Impact factor: 6.331

10.  Shaping bio-inspired nanotechnologies to target thrombosis for dual optical-magnetic resonance imaging.

Authors:  Amy M Wen; Yunmei Wang; Kai Jiang; Greg C Hsu; Huiyun Gao; Karin L Lee; Alice C Yang; Xin Yu; Daniel I Simon; Nicole F Steinmetz
Journal:  J Mater Chem B       Date:  2015-06-10       Impact factor: 6.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.